Home » Topics » Regulatory » Patents

Patents
RSS

NOS inhibitors from Merck & Co.

July 12, 1996

Potential CNS disorders treatment from Janssen

July 12, 1996

Biphenyl iodinated derivatives for X-ray diagnosis from Bracco

July 12, 1996

Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb

July 12, 1996

Cathepsin B and L inhibitors in Fujisawa's pipeline

July 12, 1996

Multidrug resistance modifiers from Vertex

July 12, 1996

Arizona Board of Regents reports antitumor pentapeptides

July 12, 1996

Protein tyrosine kinase inhibitors from Warner-Lambert

July 12, 1996

GT32-B: a novel antibacterial/antitumor immunosuppresant

July 12, 1996

Sankyo reveals potential immunosupressants

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...